CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and can afford the risks.Trading CFDs is high risk and is not suitable for everyone. Refer to our PDS and Target Market Determination. AFSL 513393
Basilea Pharmaceutica (BSLN) is a Swiss biopharmaceutical company, founded in 2000 and located in Basel, Switzerland. The company discovers, develops and commercialises innovative pharmaceutical products for fungal and bacterial infections, as well as cancer. Basilea Pharmaceutica owns such brands as Zevtera/Mabelio, Cresemba and Toctino. Since 2004, Basilea Pharmaceutica has been listed on the SIX Swiss Exchange. Follow the Basilea Pharma share price (BSLN) at Capital.com.